XYF-19 is under clinical development by Xi'An Yufan Biotechnology and currently in Phase I for Hairy Cell Leukemia.

He's just 17 years old, but Blades Brown, making his first pro start at PGA Tour's American Express, has an old-soul ...

In 2022, Parke Brown – Blade’s father – was given a somber diagnosis of bone cancer that carried with it a life expectancy of ...

XYF-19 is under clinical development by Xi'An Yufan Biotechnology and currently in Phase I for Mantle Cell Lymphoma.

This important study reveals a role for IκBα in the regulation of embryonic stem cell pluripotency. The solid data in mouse embryonic stem cells include separation of function mutations in IκBα to ...

This condition can also progress to cause acute myeloid leukemia or chronic myeloid leukemia. Hairy cell leukemia is a type of blood cancer in which the body makes too many B-cell lymphocytes. It ...

In a knee-jerk reaction to its quarter earnings for the December 2024 quarter, Shares of HCL Technologies Ltd cracked more than 9 per cent during the trading session on Tuesday on the back of ...

HCL Technologies Ltd (HCL Tech) Q3 results came more or less in line with expectations. Even as the IT major narrowed its revenue guidance, analysts said the hurdle rate for HCL Tech to now re ...

Results from a clinical trial ... Changes in Blood Cell Production Over the Lifetime Could Impact Leukemia Outcomes Dec. 5, 2024 — The first comprehensive map of the dramatic changes that take ...